Synthesis, characterization, and antimicrobial activity of hexa-coordinated cobalt (II) complexes with Salicylaldehyde-derived schiff base ligands

Key Points

• Cobalt(II) complexes exhibit significant antimicrobial activity against various pathogens.
• The study reports a minimum inhibitory concentration of 32 µg/mL in tested strains.
• Synthesis involved salicylaldehyde-derived Schiff base ligands with cobalt(II) coordination.
• Implications for using cobalt(II) complexes imply potential in developing new antimicrobial agents.